{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:15:41Z","timestamp":1781842541987,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.semarthrit.2023.152284","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T19:26:26Z","timestamp":1698953186000},"page":"152284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Cancer incidence in Familial Mediterranean Fever: A retrospective analysis"],"prefix":"10.1016","volume":"63","author":[{"given":"Sura Nur","family":"Baspinar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berkay","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyza Nur","family":"Azman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelin","family":"Guler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulgar Boran","family":"Gunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammet Kadir","family":"Tanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunay","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9561-2282","authenticated-orcid":false,"given":"Serdal","family":"Ugurlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2023.152284_bib0001","first-page":"13","article-title":"Familial Mediterranean fever: current perspectives","volume":"9","author":"S\u00f6nmez","year":"2016","journal-title":"J Inflamm Res"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152284_bib0002","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1002\/art.24458","article-title":"Familial Mediterranean Fever in the world","volume":"61","author":"Ben-Chetrit","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152284_bib0003","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10067-005-1148-z","article-title":"Possible effect of subclinical inflammation on daily life in familial Mediterranean fever","volume":"25","author":"Oz\u00e7akar","year":"2006","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152284_bib0004","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5152\/eurjrheum.2014.006","article-title":"Familial Mediterranean fever: an updated review","volume":"1","author":"Sar\u0131","year":"2014","journal-title":"Eur J Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152284_bib0005","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrrheum.2013.174","article-title":"A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin","volume":"10","author":"Ozen","year":"2014","journal-title":"Nature Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152284_bib0006","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3389\/fimmu.2017.00253","article-title":"Familial Mediterranean Fever: recent developments in pathogenesis and new recommendations for management","volume":"8","author":"\u00d6zen","year":"2017","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152284_bib0007","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1172\/JCI80007","article-title":"Immunity, inflammation, and cancer: an eternal fight between good and evil","volume":"125","author":"Shalapour","year":"2015","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152284_bib0008","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","article-title":"Inflammation and cancer: triggers, mechanisms, and consequences","volume":"51","author":"Greten","year":"2019","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152284_bib0009","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/art.40497","article-title":"Familial Mediterranean Fever: new insights into cancer immunoprevention? Comment on the article by Brenner et\u00a0al","volume":"70","author":"Bilgin","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"Part 2","key":"10.1016\/j.semarthrit.2023.152284_bib0010","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.lpm.2018.08.014","article-title":"Familial Mediterranean Fever","volume":"48","author":"Ozdogan","year":"2019","journal-title":"La Presse M\u00e9dicale"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152284_bib0011","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/art.40344","article-title":"Familial Mediterranean Fever and incidence of cancer: an analysis of 8,534 Israeli patients with 258,803 person-years","volume":"70","author":"Brenner","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152284_bib0012","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00296-019-04311-x","article-title":"Cancer incidence in familial Mediterranean fever patients: a retrospective analysis from central Anatolia","volume":"39","author":"Bilgin","year":"2019","journal-title":"Rheumatol Int"},{"issue":"7624","key":"10.1016\/j.semarthrit.2023.152284_bib0013","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"Elm","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2023.152284_bib0014","series-title":"Turkey Cancer Statistics 2018. Republic of Turkiye","author":"T\u00fcrky\u0131lmaz","year":"2022"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152284_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0002-9343(67)90167-2","article-title":"Familial Mediterranean fever. A survey of 470 cases and review of the literature","volume":"43","author":"Sohar","year":"1967","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2023.152284_bib0016","unstructured":"Dean AG S.K., Sullivan K.M., Soe M.M. OpenEpi: open source epidemiologic statistics for public health, Version 3. Available at: www.openepi.com, (accessed June 1, 2023)."},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152284_bib0017","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/oxfordjournals.aje.a112044","article-title":"Confounding and effect-modification","volume":"100","author":"Miettinen","year":"1974","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semarthrit.2023.152284_bib0018","series-title":"Epidemiologic analysis with a programmable calculator","author":"Rothman","year":"1979"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152284_bib0019","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152284_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc1252","article-title":"Cytokines in cancer pathogenesis and cancer therapy","volume":"4","author":"Dranoff","year":"2004","journal-title":"Nature Rev Cancer"},{"issue":"9255","key":"10.1016\/j.semarthrit.2023.152284_bib0021","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"The Lancet"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152284_bib0022","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ccell.2021.04.011","article-title":"Interleukin-1 in tumor progression, therapy, and prevention","volume":"39","author":"Garlanda","year":"2021","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152284_bib0023","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152284_bib0024","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s10555-010-9229-0","article-title":"Why not treat human cancer with interleukin-1 blockade?","volume":"29","author":"Dinarello","year":"2010","journal-title":"Cancer Metastasis Rev"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152284_bib0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cyto.2008.07.014","article-title":"Cytokines as a key component of cancer-related inflammation","volume":"43","author":"Germano","year":"2008","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152284_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071791","article-title":"Interleukin-1\u03b2 and cancer","volume":"12","author":"R\u00e9b\u00e9","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152284_bib0027","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.3390\/ijms19082155","article-title":"Interleukin-1 beta\u2014a friend or foe in malignancies?","volume":"19","author":"Bent","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152284_bib0028","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152284_bib0029","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/sj.cdd.4402142","article-title":"The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1\u03b2 processing","volume":"14","author":"Papin","year":"2007","journal-title":"Cell Death Different"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152284_bib0030","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","article-title":"The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators","volume":"95","author":"Centola","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152284_bib0031","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2013Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"Si\u20132","key":"10.1016\/j.semarthrit.2023.152284_bib0032","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3906\/sag-2008-11","article-title":"Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review","volume":"50","author":"Tufan","year":"2020","journal-title":"Turk J Med Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152284_bib0033","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s13023-019-1201-7","article-title":"Update on the management of colchicine resistant Familial Mediterranean Fever (FMF)","volume":"14","author":"El Hasbani","year":"2019","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152284_bib0034","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med Res Rev"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152284_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.lfs.2013.07.002","article-title":"Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma","volume":"93","author":"Lin","year":"2013","journal-title":"Life Sci"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152284_bib0036","first-page":"6269","article-title":"Anticancer effects of colchicine on hypopharyngeal cancer","volume":"37","author":"CHO","year":"2017","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152284_bib0037","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.kjms.2015.12.006","article-title":"Anticancer effects of clinically acceptable colchicine concentrations on human gastric cancer cell lines","volume":"32","author":"Lin","year":"2016","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"50","key":"10.1016\/j.semarthrit.2023.152284_bib0038","doi-asserted-by":"crossref","first-page":"e1570","DOI":"10.1097\/MD.0000000000001570","article-title":"Colchicine significantly reduces incident cancer in gout male patients: a 12-year cohort study","volume":"94","author":"Kuo","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"10.1016\/j.semarthrit.2023.152284_bib0039","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/cncr.22198","article-title":"Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis","volume":"107","author":"Arrieta","year":"2006","journal-title":"Cancer"},{"issue":"10105","key":"10.1016\/j.semarthrit.2023.152284_bib0040","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","article-title":"Effect of interleukin-1\u03b2 inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial","volume":"390","author":"Ridker","year":"2017","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152284_bib0041","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1474319","article-title":"Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study","volume":"7","author":"Isambert","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semarthrit.2023.152284_bib0042","first-page":"99","article-title":"ACO\/ARO\/AIO-21 -Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer patients: a phase I trial of the German rectal cancer study group","volume":"34","author":"Fleischmann","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"issue":"12","key":"10.1016\/j.semarthrit.2023.152284_bib0043","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2217\/fon-2020-1098","article-title":"Canakinumab with and without pembrolizumab in patients with resectable non-small-cell lung cancer: CANOPY-N study design","volume":"17","author":"Garrido","year":"2021","journal-title":"Future Oncol"},{"issue":"7","key":"10.1016\/j.semarthrit.2023.152284_bib0044","doi-asserted-by":"crossref","first-page":"e6055","DOI":"10.1097\/MD.0000000000006055","article-title":"Reduced risk of all-cancer and solid cancer in Taiwanese patients with rheumatoid arthritis treated with etanercept, a TNF-\u03b1 inhibitor","volume":"96","author":"Lan","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152284_bib0045","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/cac2.12283","article-title":"The five major autoimmune diseases increase the risk of cancer: epidemiological data from a large-scale cohort study in China","volume":"42","author":"Zhou","year":"2022","journal-title":"Cancer Commun."},{"issue":"18","key":"10.1016\/j.semarthrit.2023.152284_bib0046","doi-asserted-by":"crossref","first-page":"e3540","DOI":"10.1097\/MD.0000000000003540","article-title":"Cancer risk in patients with inflammatory systemic autoimmune rheumatic diseases: a nationwide population-based dynamic cohort study in Taiwan","volume":"95","author":"Yu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152284_bib0047","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/BOR.0b013e3282f1ecd4","article-title":"Musculoskeletal syndromes associated with malignancy (excluding hypertrophic osteoarthropathy)","volume":"20","author":"Naschitz","year":"2008","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2023.152284_bib0048","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41584-021-00741-9","article-title":"Regulation of activated T cell survival in rheumatic autoimmune diseases","volume":"18","author":"Rosetti","year":"2022","journal-title":"Nature Rev Rheumatol"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152284_bib0049","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jaut.2012.05.019","article-title":"The T cell in Sjogren's syndrome: force majeure, not spectateur","volume":"39","author":"Singh","year":"2012","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.semarthrit.2023.152284_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103185","article-title":"T cell abnormalities in systemic sclerosis","volume":"21","author":"Jin","year":"2022","journal-title":"Autoimmun Rev"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001269?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001269?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:14:00Z","timestamp":1758734040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223001269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":50,"alternative-id":["S0049017223001269"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152284","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer incidence in Familial Mediterranean Fever: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152284"}}